Daniel Labar

2.1k citations

52 papers · 1.7k indexed · h-index 22

Impact in

Radiology, Nuclear Medicine and Imaging top 1%
- Medical Imaging Techniques and Applications
- Radiopharmaceutical Chemistry and Applications
- Advanced MRI Techniques and Applications
- Cardiac Imaging and Diagnostics
Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism

Papers in ⓘ

Radiology, Nuclear Medicine and Imaging 35
- Medical Imaging Techniques and Applications 24
- Advanced MRI Techniques and Applications 12
- Radiopharmaceutical Chemistry and Applications 9
Cancer Research 13
- Cancer, Hypoxia, and Metabolism 13

Co-authors: Anne Bol (28 shared papers)Vincent Grégoire (21 shared papers)Christian Michel (7 shared papers)Anne De Volder (5 shared papers)Thierry Vander Borght (8 shared papers)John A. Lee (7 shared papers)Ann Coppens (3 shared papers)Bernard Gallez (10 shared papers)
Journals: European Journal of Nuclear Medicine and Molecular Imaging (11 papers)Radiotherapy and Oncology (5 papers)Acta Oncologica (4 papers)Contrast Media & Molecular Imaging (3 papers)Bioorganic & Medicinal Chemistry (3 papers)
Partner nations: Belgium United States France

In The Last Decade

Daniel Labar

51 papers receiving 1.6k citations

Peers

Countries citing papers authored by Daniel Labar

Since Specialization

Citations

This map shows the geographic impact of Daniel Labar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Labar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Labar more than expected).

Fields of papers citing papers by Daniel Labar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Labar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Labar. The network helps show where Daniel Labar may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Labar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Labar Line = papers co-authored together Daniel Labar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	86Y-DOTA0-d-Phe1-Tyr3-octreotide (SMT487)—a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion European Journal of Nuclear Medicine and Molecular Imaging ·François Jamar, Raffaella Barone, Isabelle Mathieu, Stéphan Walrand, Daniel Labar, Pascal Carlier, J Camps, Horst Schran, Tianling Chen, Malcolm C. Smith, Hakim Bouterfa, Roelf Valkema, Eric P. Krenning, Larry K. Kvols, Stanislas Pauwels	2003	177
2	Myocardial Blood Flow, Glucose Uptake, and Recruitment of Inotropic Reserve in Chronic Left Ventricular Ischemic Dysfunction Circulation ·Bernhard Gerber, Jean‐Louis Vanoverschelde, Anne Bol, Christian Michel, Daniel Labar, William Wijns, P. Daniel Meerburg	1996	160
3	Comparison of regional cerebral blood flow and glucose metabolism in the normal brain: effect of aging Journal of the Neurological Sciences ·M’hamed Bentourkia, Anne Bol, Adrian Ivanoiu, Daniel Labar, M. Sibomana, Ann Coppens, Christian Michel, Guy Cosnard, Anne De Volder	2000	147
4	A prospective clinical study of 18 F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy European Journal of Nuclear Medicine and Molecular Imaging ·S. Servagi-Vernat, S. Differding, François‐Xavier Hanin, Daniel Labar, Anne Bol, John A. Lee, Vincent Grégoire	2014	83
5	Changes in occipital cortex activity in early blind humans using a sensory substitution device Brain Research ·Anne De Volder, Mitzi Catalán-Ahumada, Annie Robert, Anne Bol, Daniel Labar, Ann Coppens, Christian Michel, Claude Veraart	1999	81
6	Antibody‐functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of ⁸⁹Zr‐labeled cetuximab in mice Contrast Media & Molecular Imaging ·Linda Karmani, Daniel Labar, Vanessa Valembois, V. Bouchat, Praveen Ganesh Nagaswaran, Anne Bol, J. Gillart, Philippe Levêque, Caroline Bouzin, Davide Bonifazi, Carine Michiels, Olivier Féron, Vincent Grégoire, Stéphane Lucas, Thierry Vander Borght, Bernard Gallez	2013	76
7	Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86 European Journal of Nuclear Medicine and Molecular Imaging ·Stéphan Walrand, François Jamar, Isabelle Mathieu, J Camps, Max Lonneux, M. Sibomana, Daniel Labar, Christian Michel, Stanislas Pauwels	2002	75
8	[¹⁸F]CuCF₃: A [¹⁸F]Trifluoromethylating Agent for Arylboronic Acids and Aryl Iodides Chemistry - A European Journal ·Pavel Ivashkin, Gérald Lemonnier, Jonathan Cousin, Vincent Grégoire, Daniel Labar, Philippe Jubault, Xavier Pannecoucke	2014	64
9	Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: A comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry Radiotherapy and Oncology ·Ly-Binh-An Tran, Anne Bol, Daniel Labar, Bénédicte F. Jordan, Julie Magat, Lionel Mignion, Vincent Grégoire, Bernard Gallez	2012	61
10	Production of [2-11C]thymidine for quantification of cellular proliferation with PET International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes ·Thierry Vander Borght, Daniel Labar, Stanislas Pauwels, Luc Lambotte	1991	56
11	Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: A planning study Acta Oncologica ·S. Servagi-Vernat, S. Differding, Edmond Sterpin, François‐Xavier Hanin, Daniel Labar, Anne Bol, John A. Lee, Vincent Grégoire	2015	50
12	Synthesis of [18F]-labeled EF3 [2-(2-nitroimidazol-1-yl)-N-(3,3,3-trifluoropropyl)-acetamide], a marker for PET detection of hypoxia Bioorganic & Medicinal Chemistry ·Olivier Josse, Daniel Labar, Benoît Georges, V. Grégoire, Jacqueline Marchand‐Brynaert	2001	48
13	Synthesis of [2-11C] thymidine : an imaging agent for cellular proliferation. DIAL (Catholic University of Leuven) ·Thierry Vander Borght, Daniel Labar, Stanislas Pauwels, Luc Lambotte, Christian Beckers	1990	44
14	¹⁸F-Fluoroform: a ¹⁸F-trifluoromethylating agent for the synthesis of SCF₂¹⁸F-aromatic derivatives Chemical Communications ·Elodie Carbonnel, Tatiana Besset, Thomas Poisson, Daniel Labar, Xavier Pannecoucke, Philippe Jubault	2017	44
15	[18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model European Journal of Nuclear Medicine and Molecular Imaging ·Ludwig J. Dubois, Willy Landuyt, Lieselotte Cloetens, Anne Bol, Guy Bormans, Karin Haustermans, Daniel Labar, Johan Nuyts, Vincent Grégoire, Luc Mortelmans	2008	41
16	Reprogramming of tumor metabolism by targeting mitochondria improves tumor response to irradiation Acta Oncologica ·Vanesa Bol, Anne Bol, Caroline Bouzin, Daniel Labar, John A. Lee, Guillaume Janssens, Paolo E. Porporato, Pierre Sonveaux, Olivier Féron, Vincent Grégoire	2014	32
17	Is 18F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer 14C-EF3 in animal tumor models Radiotherapy and Oncology ·Nicolas Christian, S. Deheneffe, Anne Bol, Marc De Bast, Daniel Labar, John A. Lee, Vincent Grégoire	2010	30
18	⁸⁹ Zr-Labeled Anti-Endoglin Antibody-Targeted Gold Nanoparticles for Imaging Cancer: Implications for Future Cancer Therapy Nanomedicine ·Linda Karmani, V. Bouchat, Caroline Bouzin, Philippe Levêque, Daniel Labar, Anne Bol, Gladys Deumer, Riccardo Marega, Davide Bonifazi, Vincent Haufroid, Carine Michiels, Vincent Grégoire, Olivier Féron, Stéphane Lucas, Thierry Vander Borght, Bernard Gallez	2014	30
19	Potential role of hypoxia imaging using 18F-FAZA PET to guide hypoxia-driven interventions (carbogen breathing or dose escalation) in radiation therapy Radiotherapy and Oncology ·Ly-Binh-An Tran, Anne Bol, Daniel Labar, Oussama Karroum, Vanesa Bol, Bénédicte F. Jordan, Vincent Grégoire, Bernard Gallez	2014	25
20	Comparison Between Adenoviral and Retroviral Vectors for the Transduction of the Thymidine Kinase PET Reporter Gene in Rat Mesenchymal Stem Cells Journal of Nuclear Medicine ·Véronique Roelants, Daniel Labar, Carole de Meester, Xavier Havaux, Antonio Tabilio, Sanjiv S. Gambhir, Mauro Di Ianni, Anne Bol, L Bertrand, Jean‐Louis Vanoverschelde	2008	25

About Daniel Labar

Daniel Labar is a scholar working on Radiology, Nuclear Medicine and Imaging, Cancer Research, Pharmaceutical Science, Radiation and Toxicology, having authored 52 papers that have together received 1.7k indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (24 papers), Cancer, Hypoxia, and Metabolism (13 papers), Advanced MRI Techniques and Applications (12 papers), Radiopharmaceutical Chemistry and Applications (9 papers), Advanced Radiotherapy Techniques (5 papers), Nanoplatforms for cancer theranostics (4 papers), Fluorine in Organic Chemistry (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (911 citations), Cancer Research (352 citations), Pharmaceutical Science (130 citations), Radiation (135 citations) and Otorhinolaryngology (44 citations). Daniel Labar has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Anne Bol, Vincent Grégoire, Christian Michel, Anne De Volder, Thierry Vander Borght, John A. Lee, Ann Coppens, Bernard Gallez, M. Sibomana and Stanislas Pauwels. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Radiotherapy and Oncology, Acta Oncologica, Contrast Media & Molecular Imaging and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact